SPIRIT HEALTH ANNOUNCES NEW MARKET ACCESS SERVICE - SPIRIT ACCESS
SPIRIT HEALTH GROUP ANNOUNCES NEW MARKET ACCESS CONSULTANCY SERVICE - SPIRIT ACCESS - FOR PHARMACEUTICAL, DEVICE INDUSTRY AND NHS CLIENTS
Spirit
Health Group has acquired Pathway Communications, to expand the Spirit offer to
include healthcare analytics, patient pathway simulation and implementation
services to help NHS gain maximum value from Pharmaceutical innovation
Spirit Health
Group today announces its new market access consultancy service, Spirit Access,
following the acquisition of a majority stake in patient pathway and healthcare
development experts, Pathway Communications.
As part of the
Spirit Health Group, Spirit Access will combine Pathway Communications’
knowledge of the pharmaceutical and medical technology market with Spirit
Healthcare’s resources and expertise in delivering healthcare services to the
NHS to help pharma companies show the total value of their offering to the
NHS. Spirit Access will provide data analysis, simulation and modelling,
implementation and digital solutions to its pharmaceutical and NHS
customers.
David Southern, Managing Director,
Pathway Communications, who becomes Spirit Access’ Managing Director, comments:
“We have worked closely with Spirit over a number of years and there is a
strong synergy between the companies that, combined, becomes stronger than the
two halves.
“Spirit has an extensive background in
working with NHS organisations, including CCGs and Primary Care providers, but
has a range of products that offer complementary ways for the NHS to unlock
further value from pharmaceutical and medical device products. Likewise,
Pathway Communications has a strong track record of working with pharma and
wanted to forge a relationship with an organisation which could deliver an implementation
model to help the NHS achieve the much needed cost savings and patient benefit
outcomes.”
Pathway Communications has developed a
number of patient pathway simulations for a range of disease areas – including
ophthalmology, COPD, diabetes and cancer - that allow the impact of making
change to be readily understood. Delivered to NHS customers through Spirit’s
proven implementation model, Spirit Access aims to ensure the highest quality
patient outcomes whilst optimising value from medicines budgets.
Chris Barker, CEO, Spirit Health Group,
adds: “The challenges of healthcare delivery are many, with local variation, an
ageing population, complicated pathways and ever-changing demands and
expectations on services. Addressing
each challenge requires experience and knowledge in the NHS, an understanding
of the pathway and a clear outcome to deliver from each piece of work. We know from experience that there are
tangible benefits – both in terms of patient outcomes and NHS financial efficiencies
– being achieved today through collaborative approaches to healthcare delivery.
“Spirit Access’ aim is to use our
digital technology, implementation services and pathway experience to work with
pharmaceutical & medical technology companies to add value for the NHS,
Industry and most importantly Patients.”